|
|
Volumn 58, Issue 10, 1996, Pages 159-170
|
|
Levodopa but not bromocriptine induces AP-1 and CREB DNA-binding activity in the dopamine-depleted striatum of the rat
a
|
|
Author keywords
6 hydroxydopamine; AP 1; Bromocriptine; CREB; Levodopa; SKF38393; Striatum; Transcription factor
|
|
Indexed keywords
2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE;
ANTIPARKINSON AGENT;
APOMORPHINE;
BENSERAZIDE;
BROMOCRIPTINE;
CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;
DNA BINDING PROTEIN;
DOPAMINE;
DOPAMINE 1 RECEPTOR;
DOPAMINE 1 RECEPTOR STIMULATING AGENT;
DOPAMINE 2 RECEPTOR STIMULATING AGENT;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
OXIDOPAMINE;
PROTEIN C FOS;
PROTEIN JUN;
TRANSCRIPTION FACTOR AP 1;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BRAIN INJURY;
CIRCLING BEHAVIOR;
CONTROLLED STUDY;
CORPUS STRIATUM;
DEPLETION;
DRUG MECHANISM;
INTRAPERITONEAL DRUG ADMINISTRATION;
MALE;
NEUROCHEMISTRY;
NIGRONEOSTRIATAL SYSTEM;
NONHUMAN;
PARKINSON DISEASE;
PROTEIN INDUCTION;
RAT;
SUPERSENSITIVITY;
ANIMAL;
ANIMAL BEHAVIOR;
BIOSYNTHESIS;
DISEASE MODEL;
DRUG EFFECT;
DRUG POTENTIATION;
METABOLISM;
MOLECULAR GENETICS;
NUCLEOTIDE SEQUENCE;
SPRAGUE DAWLEY RAT;
2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE;
ANIMALS;
ANTIPARKINSON AGENTS;
BASE SEQUENCE;
BEHAVIOR, ANIMAL;
BROMOCRIPTINE;
CORPUS STRIATUM;
CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN;
DISEASE MODELS, ANIMAL;
DOPAMINE;
DOPAMINE AGONISTS;
LEVODOPA;
MALE;
MOLECULAR SEQUENCE DATA;
PARKINSON DISEASE, SECONDARY;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, DOPAMINE D1;
TRANSCRIPTION FACTOR AP-1;
|
|
EID: 0343832088
PISSN: 00243205
EISSN: None
Source Type: Journal
DOI: 10.1016/0024-3205(96)00021-5 Document Type: Article |
|
Times cited : (10)
|
|
References (30)
|
